University of California

Scientists

Comparative Study of Cu-64-DOTA-HB22.7 Administration Routes in Xenograft-Bearing Mice

Researchers at the University of California conducted a study comparing the tumor-specific targeting, pharmacokinetics, and biodistribution of Cu-64-DOTA-HB22.7, a potential radioimmunotherapeutic and imaging agent, when administered intravenously, intraperitoneally, and subcutaneously to xenograft-bearing mice. The study aimed to evaluate the effectiveness of different administration routes in achieving equivalent tumor targeting,

Scientists

Impaired Antioxidant Activity of High-Density Lipoprotein in Chronic Kidney Disease Contributes to Atherosclerosis

Chronic kidney disease (CKD) significantly increases the risk of cardiovascular disease and mortality, which is partly attributed to the accelerated atherosclerosis and inflammation that occur concurrently with CKD. CKD is characterized by oxidative stress, inflammation, and high-density lipoprotein (HDL) deficiency, which are key factors that promote atherosclerosis. The protective mechanisms